Full Press Release Details
Ultragenyx to Participate at Investor Conferences in November.
RARE
Ultragenyx to Participate at Investor Conferences in November
Key Takeaway: Ultragenyx to Participate at Investor Conferences in November
Price reaction · baseline $39.97 (2023-11-17 close) · clean, no other RARE news in the window
day 0 close · peak
-1.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia